Preclinical data in type 1 diabetes organoid model demonstrate MTX-101 can reestablish functionality of pancreatic beta cells Phase 1 clinical study underway to evaluate MTX-101 in healthy adults...

House of Dank, a prominent name in Michigan's cannabis community, is proud to announce the return of two signature charitable events this holiday season: the Annual Joint Efforts Thanksgiving...

— The T cell therapy company heads to ASH 2024 next month to introduce its novel allogeneic protection and cytokine engineering strategies to support the development of potent and persistent...

Data to be presented from an oral azacitidine plus cedazuridine (ASTX030) combination phase 1 open-label dose escalation and expansion trial Findings to be shared from a study analyzing...

- Initial data from the ongoing Phase 1b study evaluating R289, a dual IRAK1/4 inhibitor, in LR-MDS - Additional data for REZLIDHIA® (olutasidenib) in patients with mIDH1 AML and MDS SOUTH SAN...